Bioanalysis testing services delivery order number: 2017-0002; in vivo pharmacokinetic services
Ended Awarded Last action
- Contract number
- HHSN27100011
- Awardee
-
Pharmaron, Inc. UEI L8NQAFSTPSY9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $143,550
Award facts
- Opportunity
-
- 2015306 Solicitation number
- Sources Sought Notice - SCREWDRIVER, OFFSET, RATCHET, 1/4 inch SLOTTED, PHILLIPS #2 Award Notice · Posted Aug 21, 2015
- Contract value 100% obligated
- $143,550.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Louisville, KY 40202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,490 | |
| Original award | $149,040 |
About this award
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $143,550.00 firm fixed-price delivery order falls under the NIH Bioanalysis Testing Services 2015-2020 contract vehicle, which provides preclinical research services to support drug discovery and development. The contract does not have a set-aside designation.
Pharmaron, a minority-owned, for-profit organization specializing in preclinical services, will conduct pharmacokinetic assessments, toxicity studies, and ion channel testing to support NIDA's drug development initiatives. The company has a long history of supporting NIH research, particularly for the National Center for Advancing Translational Sciences (NCATS) and NIDA, through similar firm fixed-price contracts. Pharmaron's global capabilities and expertise spanning various stages of the drug development process make them a key partner in advancing potential new therapies.
Quick answers
Who was awarded contract HHSN27100011?
HHSN27100011 was awarded to Pharmaron, Inc. by National Institute on Drug Abuse (National Institutes of Health) on November 1, 2016.
How much is contract HHSN27100011 worth?
The government has obligated $143,550 on HHSN27100011.
Is contract HHSN27100011 an order under another contract?
Yes. HHSN27100011 is a delivery order under HHSN271201500025I, an indefinite delivery contract, on NIH Bioanalysis Testing Services 2015-2020.
Was contract HHSN27100011 competed?
The extent of competition for HHSN27100011 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award